Efficacy and Safety of Tenofovir Alafenamide (TAF) at 96 Weeks in Chronic HBV (CHB) Patients with Risk Factors for Use of Tenofovir Disoproxil Fumarate (TDF)

Buti M., Stepanova T., ÇELEN M. K., Flisiak R., Ryder S. D., Streinu-Cercel A., ...More

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 October 2017, vol.66, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 66
  • City: Washington
  • Country: Kiribati
  • Bursa Uludag University Affiliated: Yes